Clinical Trials Logo

Clinical Trial Summary

This study evaluates the efficacy of Mutli-Im® transepithelial components in the inhibition of bacterial adhesion. The control group will be the Multi-Im® transepithelial component with the conventional surface (Multi-IM® Machined) and the experimental group will be the Multi-Im transepithelial components with the Ti-Golden® surface (Multi-Im Golden) or with the nanogolden surface (Multi-Im® nanogolden). Periodontal indices and biofilformation will be assessed during 2 months after implant loading. Metagenomic analysis and PCR technique will be implemented to assess the biofilm formation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03554876
Study type Interventional
Source Fundación Eduardo Anitua
Contact Mohammad Hamdan, PhD
Phone 0034945160653
Email mohammad.hamdan@bti-implant.es
Status Recruiting
Phase N/A
Start date July 16, 2018
Completion date December 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04926493 - Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Patients at Increased Risk for the Development of Ventilator-associated Pneumonia in the Intensive Care Unit
Active, not recruiting NCT04841226 - Randomized Study of Silq Urinary Catheter N/A